LB-009 - POPULATION PHARMACOKINETIC ANALYSIS OF GARADACIMAB IN SEVERE COVID-19 SUBJECTS.
A. Sharma1, D. Pawaskar1, F. Glassman1, P. Shore1, J. Tarrant1, K. Quazi1, A. Roberts2, B. Darby2, H. McCallum2, M. Lichtfuss2, M. Larbig1; 1CSL Behring, King of Prussia, PA, USA, 2CSL Behring, Victoria, Australia.
.png)